Skip to main content

Day: July 18, 2024

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2024 financial results on Thursday, August 1, 2024. Vericel’s management will host a conference call and webcast at 8:30 a.m. (ET) to discuss its financial results and business highlights. The live webcast can be accessed on the Investor Relations section of the Vericel website at http://investors.vcel.com/events-presentations. Please visit the site at least 15 minutes prior to the scheduled start time in order to register and download the required audio software, if necessary. Presentation slides for the conference call will be available on the webcast and on the Investor Relations section of the Vericel...

Continue reading

DriveItAway Holdings, Inc. Partners with Corporate Claims Management for Maintenance, Service and Accident Management for its Rapidly Expanding Fleet

Philadelphia, PA, July 18, 2024 (GLOBE NEWSWIRE) — – DriveItAway’s national company-owned fleet is expanding rapidly all over the country, following its recent vehicle financing agreement, requiring professional fleet management for vehicle maintenance, mechanical service, and accident management – Corporate Claims Management is one of the oldest and largest independent comprehensive fleet service and accident management companies in the US, and for 31 years has provided these services to national corporate fleets throughout the United States and Canada – This partnership with Corporate Claims Management will allow DriveItAway to quickly and seamlessly scale its company-owned fleet throughout the country, with the best driver-focused quality care, without the need to add additional overheadPHILADELPHIA, PA,...

Continue reading

MGP Ingredients to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024

ATCHISON, Kan., July 18, 2024 (GLOBE NEWSWIRE) — MGP Ingredients, Inc. (Nasdaq:MGPI), a leading provider of branded and distilled spirits and food ingredient solutions, today announced that it will report results for the second quarter ended June 30, 2024, on Thursday, August 1, at 10 a.m. ET. The company expects to release its financial results before the markets open. Management, including David Bratcher, CEO and president, and Brandon Gall, CFO, will hold a conference call to discuss these results. Please visit the “News and Events” section of the company’s Investor Relations section at ir.mgpingredients.com/news-events to access the live webcast. Investors can also dial 844-308-6398 (domestic) or 412-717-9605 (international) to listen to the live call. A replay will be available on the company’s website after the call concludes. About...

Continue reading

InterDigital Announces Date for Second Quarter 2024 Financial Results

WILMINGTON, Del., July 18, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will release its second quarter 2024 financial results before the market open on Thursday, August 1, 2024. InterDigital executives will host a conference call that same day at 10:00 a.m. Eastern Time (ET) to discuss the company performance. For a live webcast of the conference call visit www.interdigital.com and click on the “Webcast” link on the Investors page. The company encourages participants to take advantage of the webcast option. For telephone access to the conference call, visit www.interdigital.com and click on the “Dial-In Registration” link on the Investors page. Registration is necessary to obtain a dial-in phone number and PIN to...

Continue reading

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Nose-to-Brain Drug Delivery Shows Promising Patient Safety and Therapeutic Benefit The Device and CMC Development Master Plan is designed to support IND-enabling studies SARASOTA, FL, July 18, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider. Resyca is a joint venture between Bespak Group and Medspray Pharma BV which manufactures the formulation-specific microchip-based spray system chosen by Silo for its lead candidate SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD). “The...

Continue reading

Significant Citizen Interest in the Immersive Workshop

Falco Resources Thanks All Participants MONTREAL, July 18, 2024 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX-V: FPC) (“Falco” or the “Corporation”) is delighted with citizen participation in the immersive public workshop which was held on July 17th at the Rouyn-Noranda Convention Center. The population was invited to experience sound and vibration simulations and meet acoustics experts. In addition to explaining the sound and vibration phenomena that surround us, the evening aimed to collect the concerns, understandings and proposals for improvement formulated by citizens regarding Falco’s Horne 5 Project. Martin Duclos, Director, Environment and Community Relations, said: “All comments will be read carefully and each question will be answered. At Falco, every opinion counts, helps fuel our thinking and plays an important role...

Continue reading

NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer’s Association International Conference

SANTA ANA, Calif., July 18, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer (“NK”) cell therapeutics, today announced that it will present new biomarker data on SNK01 (autologous non-genetically modified NK cell therapy) in Alzheimer’s disease during a poster presentation at the upcoming Alzheimer’s Association International Conference (“AAIC”) to be held in Philadelphia, PA at the Pennsylvania Convention Center and online from July 28 – August 1, 2024. NKGen will present data on SNK01’s ability to reduce α-synuclein in Alzheimer’s patients, which is significant given that α-synuclein has been shown to correlate with worse cognitive function...

Continue reading

MARA Schedules Conference Call for Second Quarter 2024 Financial Results

Earnings Webcast and Conference Call Set for Thursday, August 1, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, July 18, 2024 (GLOBE NEWSWIRE) — MARA (NASDAQ: MARA) (“MARA” or the “Company”), a global leader in leveraging digital asset compute to support the energy transformation, will hold a webcast and conference call on Thursday, August 1, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2024. Financial results will be published in a press release prior to the call and available on the investor relations section of the Company’s website. To register to participate in the conference call or to listen to the live audio webcast, please use this link. The webcast will also be broadcast live and available for replay via the investor relations section of the Company’s...

Continue reading

QuestionPro Acquires Cmiles CX

Cmiles CX’s on-site, emoji-based experience rating technology combined with QuestionPro’s leading survey-based customer experience (CX) platform creates a truly omni-channel approach to help brands more fully measure satisfaction and loyalty AUSTIN, Texas, July 18, 2024 (GLOBE NEWSWIRE) — QuestionPro, a global leader in survey and research, data and insights services, has acquired Cmiles CX, a developer of 360o customer experience and feedback tracking technology. QuestionPro will integrate Cmiles CX’s technology into its platform to create a truly omni-channel approach to help brands more fully measure customer satisfaction and loyalty. This strategic move marks QuestionPro’s entry into the Egyptian market, showcasing its commitment to transforming the regional CX landscape. QuestionPro leverages a wide range of AI...

Continue reading

trivago N.V.’s Second Quarter 2024 Earnings Release Scheduled for July 30, 2024; Webcast Scheduled for July 31, 2024

trivago N.V.’s Second Quarter 2024 Earnings Release Scheduled for July 30, 2024; Webcast Scheduled for July 31, 2024 DÜSSELDORF, GERMANY – July 18, 2024 – trivago N.V. (NASDAQ: TRVG) announced today that it will release its financial results for the second quarter for the period ended June 30, 2024 on Tuesday, July 30, 2024 after market close. On Wednesday, July 31, 2024, trivago N.V.’s management will conduct a webcast beginning at 2:15 PM CEST / 8:15 AM EDT. These items will be available in the Investor Relations section of the company’s website at https://ir.trivago.com/. A replay of the call is expected to be available for at least three months. About trivago N.V. trivago N.V. (NASDAQ: TRVG) is a global hotel and accommodation search platform. We are focused on reshaping the way travelers search for and compare...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.